We recently identified a specific aggressive PDAC subtype marked by elevated expression of the cancer stem cell marker aldehyde dehydrogenase 1 family member A3 (ALDH1A3), which is associated with adverse prognosis in various cancers [7, 8]. Here, ALDH1A3 is linked to cancer.